Diabetes is the leading cause of vision loss in people between 18 and 64 years old, according to the American Diabetes Association — and the best way to prevent this is to control blood sugar levels.

A study links semaglutide -- the ingredient in Ozempic -- with a condition that causes vision loss. Here's what we know about semaglutide and eye health. Jessica was a writer on the Wellness team, ...

World-renowned singer-songwriter Elton John confirmed he has lost sight in his right eye after suffering from a severe infection. On the opening night of his musical adaptation of "The Devil Wears ...

Share on Pinterest Research on GLP-1 drugs and eye health has been inconsistent, but experts say the risk of serious eye disease is generally low. Getty Images/Hiraman Studies have linked GLP-1 ...

Please provide your email address to receive an email when new articles are posted on . Errors of refraction and strabismic amblyopia were the most common causes of low vision. Retinal diseases most ...

When James Norris, a 56-year-old mechanic from Roxbury, New Jersey, went on a low dose of Mounjaro, a GLP-1 medication similar to Ozempic, to lose weight in March 2023, he thought it would be a ...

Visual distortions can affect your ability to see normally. Often called visual disturbances, they can cause changes in ...

Retinitis is an eye condition where the tissue at the back of the eyeball becomes inflamed. It can lead to reduced vision and vision loss. The tissue at the back of the eye is known as the retina. It ...

Dear Savvy Senior, Can you recommend some good resources or products that can help seniors with severe vision loss? My wife ...

A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following a recent study that suggests a link between the medications and a sudden, ...

Competition to deploy commercial brain-computer interfaces is heating up. Science Corporation—a competitor to Neuralink founded by the former president of Elon Musk’s brain-interface venture—has ...